Ticker
VIVSCompany Name
VIVOSIM LABS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Net Income Common Stock | Return on Assets |
---|---|---|---|
6/30/2025 | $ 11.98M | $ -1.99M | -16.59% |
3/31/2025 | $ 14.65M | $ -2.49M | -16.98% |
12/31/2024 | $ 3.84M | $ -12.38M | -322.19% |
9/30/2024 | $ 6.75M | $ -12.54M | -185.7% |
6/30/2024 | $ 9.47M | $ -13.99M | -147.7% |
3/31/2024 | $ 6.35M | $ -14.67M | -231.08% |
12/31/2023 | $ 8.88M | $ -19.09M | -214.9% |
9/30/2023 | $ 11.16M | $ -18.75M | -167.95% |
6/30/2023 | $ 14.76M | $ -18.07M | -122.47% |
3/31/2023 | $ 20.31M | $ -17.26M | -84.97% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Assets
(=) ROA
ROA for VIVOSIM LABS INC is calculated as follows: Net Inc. Cmn. [ $ -17.81M ] / Assets [ $ 20.64M ]
(=) ROA [ -86.28% ]
Minimum
Dec 31, 2024
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.44K |
---|---|
min | -33.4% |
max | 33.98% |
average | 0.12% |
median | 1.53% |
std | 10.61% |